Q09472 (EP300_HUMAN) Homo sapiens (Human)
Histone acetyltransferase p300 UniProtKBProtein AtlasInterProSTRINGInteractive Modelling
2414 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
56 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Cryo-EM structure of p300-p53 protein complex |
Heteromer P04637; | 100 | ||||
| Cryo-EM structure of the p300 catalytic core bound to the H4K12acK16ac nucleosome, class 2 (4.8 ang… |
Heteromer P04908; P06899; P62805; P68431; | 100.0 | ||||
| Cryo-EM structure of nucleosome in complex with p300 acetyltransferase catalytic core (complex I) |
Heteromer P04908; P06899; P62805; P68431; | 99.78 | ||||
| Cryo-EM structure of the p300 catalytic core bound to the H4K12acK16ac nucleosome, class 1 (4.7 ang… |
Heteromer P04908; P06899; P62805; P68431; | 100.0 | ||||
| Cryo-EM structure of the p300 catalytic core bound to the H4K12acK16ac nucleosome, class 4 (4.5 ang… |
Heteromer P04908; P06899; P62805; P68431; | 100.0 | ||||
| Cryo-EM structure of the p300 catalytic core bound to the H4K12acK16ac nucleosome, class 1 (3.2 ang… |
Heteromer P04908; P06899; P62805; P68431; | 100.0 | ||||
| Cryo-EM structure of the p300 catalytic core bound to the H4K12acK16ac nucleosome, class 2 (3.9 ang… |
Heteromer P04908; P06899; P62805; P68431; | 100.0 | ||||
| Transcription factor dimerization activates the p300 acetyltransferase |
Heteromer P62799; | 100 | 4×ZN; | |||
| Crystal structure of the p300 TAZ2 domain bound to MEF2 on DNA |
Heteromer Q02078; | 100.0 | 3×ZN; | |||
| NMR Structures of the HIF-1alpha CTAD/p300 CH1 Complex |
Heteromer Q16665; | 100 | 3×ZN; | |||
| Solution structure of the CITED2 transactivation domain in complex with the p300 CH1 domain |
Heteromer Q99967; | 100 | 3×ZN; | |||
| Crystal structure of p300 CH1 domain in complex with CITIF (a CITED2-HIF-1alpha hybrid) |
Heteromer Q16665; Q99967; | 100 | 3×ZN; | |||
| NMR solution structures of p300 TAZ2 domain in complex with BRD4-NUT F1c domain binding motif #1 |
Heteromer Q86Y26; | 95.56 | 3×ZN; | |||
| Solution NMR structure of the p300 Taz2:ETAD1 complex |
Heteromer P15923; | 95.56 | ||||
| NMR-derived ensemble of the TAZ2 domain of p300 bound to the microphthalmia-associated transcriptio… |
Heteromer O75030; | 95.56 | 3×ZN; | |||
| Structural Basis for the Regulation of p53 Function by p300 |
Heteromer P04637; | 95.56 | ||||
| Characterization of the p300 Taz2-p53 TAD2 Complex and Comparison with the p300 Taz2-p53 TAD1 Compl… |
Heteromer P04637; | 95.56 | ||||
| Structural basis for autoinhibition of the acetyltransferase activity of p300 | homo-2-mer | 99.79 | 7×ZN; 2×01K; | |||
| Transcription factor dimerization activates the p300 acetyltransferase | homo-2-mer | 99.8 | 7×ZN; 2×01K; | |||
| Crystal structure of p300 ZZ domain in complex with histone H3 peptide | homo-2-mer | 97.96 | 4×ZN; 2×CL; | |||
| Cryo-EM structure of p300 | monomer | 100.0 | ||||
| Crystal structure of the p300 acetyltransferase catalytic core with butyryl-coenzyme A. | monomer | 99.78 | 4×ZN; 1×BCO; 3×GOL; 1×DMS; 1×CL; | |||
| Crystal structure of the p300 acetyltransferase catalytic core with crotonyl-coenzyme A. | monomer | 99.78 | 4×ZN; 1×COO; 3×GOL; | |||
| Crystal structure of the p300 acetyltransferase catalytic core with propionyl-coenzyme A. | monomer | 99.79 | 4×ZN; 1×1VU; 1×DMS; 2×GOL; | |||
| Human P300 complexed with a proline-based inhibitor | monomer | 99.75 | 2×ZN; 2×EDO; 1×C0C; | |||
| Human P300 complexed with a glycine-based inhibitor | monomer | 99.75 | 2×ZN; 1×EDO; 1×C3I; 1×ACT; | |||
| Crystal structure of the p300 acetyltransferase catalytic core with coenzyme A. | monomer | 99.78 | 4×ZN; 1×COA; | |||
| Crystal structure of EP300 HAT domain in complex with compound 7 | monomer | 99.72 | 3×ZN; 1×6TI; | |||
| Crystal structure of EP300 HAT domain in complex with compound 10 | monomer | 99.72 | 3×ZN; 1×KQO; | |||
| Crystal structure of EP300 HAT domain in complex with compound 11 | monomer | 99.72 | 3×ZN; 1×6YI; | |||
| Crystal structure of EP300 HAT domain in complex with compound (+)-3 | monomer | 99.71 | 3×ZN; 1×6QI; | |||
| Human P300 complexed with an azaindazole inhibitor | monomer | 99.69 | 1×ETL; | |||
| Crystal structure of p300 histone acetyltransferase domain in complex with a bisubstrate inhibitor,… | monomer | 99.37 | 5×BR; 1×01K; | |||
| Crystal structure of p300 histone acetyltransferase domain in complex with Acetyl-Coenzyme A | monomer | 99.7 | 1×ACO; 1×DMS; | |||
| Crystal structure of p300 histone acetyltransferase domain in complex with Coenzyme A | monomer | 99.7 | 2×PEG; 1×DMS; 1×COA; | |||
| Crystal structure of p300 histone acetyltransferase domain in complex with an inhibitor, Acetonyl-C… | monomer | 99.7 | 1×SOP; 3×DMS; | |||
| Crystal structure of the p300 acetyltransferase domain with AcCoA competitive inhibitor 1 | monomer | 100.0 | 1×QRY; 2×CL; 1×SO4; | |||
| Crystal structure of the p300 acetyltransferase domain with allosteric inhibitor CPI-076 and CoA | monomer | 99.57 | 1×COA; 1×OK7; | |||
| Crystal structure of the p300 acetyltransferase domain with peptide-competitive inhibitor 2 | monomer | 99.57 | 1×COA; 1×QS4; 1×DMS; | |||
| The novel p300/CBP inhibitor A-485 uncovers a unique mechanism of action to target AR in castrate r… | monomer | 100 | 1×6TF; 1×NA; | |||
| Crystal structure of the p300 acetyltransferase domain with AcCoA competitive inhibitor 12 | monomer | 100 | 1×QSD; 2×SO4; 1×CL; | |||
| Crystal structure of the p300 acetyltransferase domain with allosteric inhibitor CPI-090 and CoA | monomer | 99.57 | 1×COA; 1×OJ7; | |||
| Discovery of Spirohydantoins as Selective, Orally Bioavailable Inhibitors of p300/CBP Histone Acety… | monomer | 100 | 1×Y2P; | |||
| Crystal structure of the p300 acetyltransferase domain with AcCoA competitive inhibitor 17 | monomer | 100 | 2×SO4; 1×CL; 1×QS1; | |||
| Crystal structure of the bromodomain of human EP300 bound to the inhibitor XDM1 | monomer | 100 | 1×XDM; 2×SO4; 5×EDO; | |||
| Crystal structure of EP300 bromodomain in complex with SGC-CBP30 chemical probe | monomer | 100 | 1×2LO; 1×IPA; | |||
| Crystal structure of the bromodomain of human Ep300 bound to the inhibitor XDM3d | monomer | 100 | 2×71Y; 2×ACT; | |||
| Crystal structure of the human bromodomain of EP300 bound to the inhibitor XDM-CBP | monomer | 100 | 1×99E; 4×EDO; | |||
| Bromodomain of EP300 liganded with BMS-536924 | monomer | 100 | 1×N6I; 1×PE5; 7×EDO; | |||
| Crystal Structure of the Bromodomain of Human EP300 | monomer | 100 | 1×CL; 1×PEG; | |||
| Bromodomain of EP300 liganded with CCS-1477 | monomer | 100 | 1×JHL; 1×EDO; 6×NI; | |||
| Crystal structure of the Taz2 domain of p300 | monomer | 96.33 | 3×ZN; 4×SO4; | |||
| Crystal structure of the Taz2:C/EBPepsilon-TAD chimera protein | monomer | 95.56 | 3×ZN; 1×TCE; 1×TAM; 1×ACN; | |||
| Solution structure of p300Taz2-p73TA1 | monomer | 95.56 | 3×ZN; | |||
| NMR solution structures of p300 TAZ2 domain in complex with BRD4-NUT F1c domain binding motif #2 | monomer | 95.56 | 3×ZN; | |||
| Solution Structure of p300Taz2-p63TA | monomer | 95.56 | 3×ZN; | |||
5 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 6gyr.2.A | monomer | 0.62 | 3×ZN; | 99.49 | ||
| 1p4q.1.B | monomer | 0.61 | 3×ZN; | 100.00 | ||
| 8han.1.I | monomer | 0.58 | 87.16 | |||
| 8haj.1.K | monomer | 0.58 | 100.00 | |||
| 2kwf.1.A | monomer | 0.52 | 89.66 | |||